Malignant rectal tumor Malignant rectal tumor
Conditions
Interventions
pNPWT using Prevena after primary suture closure of a perineal wound after APR for 1 week.
Primary Prevention
prophylactic negative pressure wound therapy, pNPWT
Sponsors
Obama Kazutaka
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients undergoing abdominoperineal resection for malignant rectal tumor 2) Meet the insurance requirements for the PREVENA incision management system (undergoing preoperative treatment (Neoadjuvant chemotherapy: NAC, Neoadjuvant chemoradiotherapy: NACRT, Total neoadjuvant therapy: TNT), BMI is 30 or more, hemoglobin A1c is 7.0% or more in NGSP, receiving steroid therapy, chronic maintenance dialysis, and/or malnutrition) 3) 18 years old and over, both sex, ECOG-PS is 0 or 1 4) Written consent to participate in this study
Exclusion criteria
Exclusion criteria: 1) Emergency surgery cases 2) Cases where primary wound closure is undesirable because of obviously contaminated/infected wound 3) Myocutaneous flap reconstruction cases 4) Cases with allergies or hypersensitivity to silver or acrylic adhesives 5) Others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate of SSI for the perineal wound within 30 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications other than the perineal wound SSI Postoperative hospital stay Completion rate of pNPWT | — |
Contacts
Public ContactTakuya Takami
Kyoto University Graduate School of Medicine
Outcome results
None listed